FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171663285> ?p ?o ?g. }

• W3171663285 endingPage "157" @default.
• W3171663285 startingPage "150" @default.
• W3171663285 abstract "Abstract Immunoglobulin G (IgG) anti‐GM1 antibodies, the most common autoantibodies in Guillain–Barré syndrome (GBS), have diverse characteristics regarding IgG subclass, complement activation, affinity and fine specificity. In this review, an update on multifaceted aspects of IgG anti‐GM1 antibodies is provided, emphasizing their roles in creating a varying clinical picture of GBS and in developing pure motor neuropathy after antecedent infection. Diversity in IgG subclass and cross‐reactivity, both of which are closely related to the type of antecedent infection, appears to cause the variation in clinical features and severity of the disease. The environment around GM1 expression in neural tissue is thought to interfere with the binding of anti‐GM1 antibodies by modulating the immunoreactive epitope, allowing only anti‐GM1 antibodies with specific fine specificity to bind to the GM1 ganglioside. This might create the characteristic clinical picture of pure motor neuropathy in anti‐GM1‐positive GBS, although GM1 is present equally in motor and sensory nerves. The environment around the GM1 epitope on Campylobacter jejuni , the most frequently identified agent in antecedent infections of GBS, might also be important in creating diversity in the fine specificity of anti‐GM1 antibodies, possibly preventing the development of GBS in most patients with enteritis by the GM1 epitope‐bearing C . jejuni . Because there remains no direct evidence indicative that diversity of anti‐GM1 antibodies is involved in the development of GBS, further study is required." @default.
• W3171663285 created "2021-06-22" @default.
• W3171663285 creator A5007867102 @default.
• W3171663285 date "2021-07-08" @default.
• W3171663285 modified "2023-09-25" @default.
• W3171663285 title "Multifaceted features of immunoglobulin G anti‐GM1 antibodies in Guillain–Barré syndrome" @default.
• W3171663285 cites W108555030 @default.
• W3171663285 cites W1587041537 @default.
• W3171663285 cites W1823312016 @default.
• W3171663285 cites W1968278997 @default.
• W3171663285 cites W1975092222 @default.
• W3171663285 cites W1976667314 @default.
• W3171663285 cites W1982913734 @default.
• W3171663285 cites W1983505211 @default.
• W3171663285 cites W1988271739 @default.
• W3171663285 cites W1994325619 @default.
• W3171663285 cites W1995085418 @default.
• W3171663285 cites W1995175104 @default.
• W3171663285 cites W1996378169 @default.
• W3171663285 cites W1996659034 @default.
• W3171663285 cites W2008753599 @default.
• W3171663285 cites W2009276375 @default.
• W3171663285 cites W2013153064 @default.
• W3171663285 cites W2015728729 @default.
• W3171663285 cites W2022509550 @default.
• W3171663285 cites W2023399130 @default.
• W3171663285 cites W2024981456 @default.
• W3171663285 cites W2027139906 @default.
• W3171663285 cites W2031879697 @default.
• W3171663285 cites W2034774690 @default.
• W3171663285 cites W2035512416 @default.
• W3171663285 cites W2038602330 @default.
• W3171663285 cites W2038646891 @default.
• W3171663285 cites W2039518664 @default.
• W3171663285 cites W2041053334 @default.
• W3171663285 cites W2046601895 @default.
• W3171663285 cites W2047020301 @default.
• W3171663285 cites W2052045063 @default.
• W3171663285 cites W2062818125 @default.
• W3171663285 cites W2062831260 @default.
• W3171663285 cites W2065347473 @default.
• W3171663285 cites W2067890699 @default.
• W3171663285 cites W2068751098 @default.
• W3171663285 cites W2074395026 @default.
• W3171663285 cites W2074900278 @default.
• W3171663285 cites W2082090644 @default.
• W3171663285 cites W2085076442 @default.
• W3171663285 cites W2085681586 @default.
• W3171663285 cites W2085970433 @default.
• W3171663285 cites W2097756798 @default.
• W3171663285 cites W2101844715 @default.
• W3171663285 cites W2106833014 @default.
• W3171663285 cites W2108479078 @default.
• W3171663285 cites W2121636757 @default.
• W3171663285 cites W2126962846 @default.
• W3171663285 cites W2131052872 @default.
• W3171663285 cites W2136295686 @default.
• W3171663285 cites W2138165257 @default.
• W3171663285 cites W2140355522 @default.
• W3171663285 cites W2145992785 @default.
• W3171663285 cites W2147751818 @default.
• W3171663285 cites W2154045350 @default.
• W3171663285 cites W2169656611 @default.
• W3171663285 cites W2170260599 @default.
• W3171663285 cites W2292029649 @default.
• W3171663285 cites W2297403758 @default.
• W3171663285 cites W2313469424 @default.
• W3171663285 cites W2335127767 @default.
• W3171663285 cites W2799816764 @default.
• W3171663285 cites W2799949227 @default.
• W3171663285 cites W2884386604 @default.
• W3171663285 cites W3092264819 @default.
• W3171663285 cites W3136425814 @default.
• W3171663285 cites W3154449391 @default.
• W3171663285 cites W649881035 @default.
• W3171663285 doi "https://doi.org/10.1111/cen3.12653" @default.
• W3171663285 hasPublicationYear "2021" @default.
• W3171663285 type Work @default.
• W3171663285 sameAs 3171663285 @default.
• W3171663285 citedByCount "1" @default.
• W3171663285 countsByYear W31716632852023 @default.
• W3171663285 crossrefType "journal-article" @default.
• W3171663285 hasAuthorship W3171663285A5007867102 @default.
• W3171663285 hasConcept C159047783 @default.
• W3171663285 hasConcept C159654299 @default.
• W3171663285 hasConcept C163764329 @default.
• W3171663285 hasConcept C195616568 @default.
• W3171663285 hasConcept C203014093 @default.
• W3171663285 hasConcept C2776194381 @default.
• W3171663285 hasConcept C2776957140 @default.
• W3171663285 hasConcept C2777119779 @default.
• W3171663285 hasConcept C2778691916 @default.
• W3171663285 hasConcept C2780632150 @default.
• W3171663285 hasConcept C2781200757 @default.
• W3171663285 hasConcept C523546767 @default.
• W3171663285 hasConcept C54355233 @default.
• W3171663285 hasConcept C71924100 @default.
• W3171663285 hasConcept C86803240 @default.

• next